Switching from latanoprost or travoprost ophthalmolic solution to tafruprost and timolol fixed ophthalmic solutio
Not Applicable
- Conditions
- Primary open angle glaucoma and ocular hypertension
- Registration Number
- JPRN-UMIN000015823
- Lead Sponsor
- niversity of Yamanashi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Severe respiratory diseases Severe systemic diseases Allegic reaction against contents of the experimental compounds
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of intraocular pressure Topical and systemic adverse effects
- Secondary Outcome Measures
Name Time Method